Lunai Bioworks
LNAI
33 hedge funds and large institutions have $10.4M invested in Lunai Bioworks in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 3 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
52% more capital invested
Capital invested by funds: $6.86M → $10.4M (+$3.54M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 32 → 33 (+1)
0% more ownership
Funds ownership: 0.06% → 0.07% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$437K |
| 2 |
State Street
Boston,
Massachusetts
|
+$119K |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$105K |
| 4 |
Bank of New York Mellon
New York
|
+$57K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$115K |
| 2 |
JP Morgan Chase
New York
|
-$35.9K |
| 3 |
Millennium Management
New York
|
-$33K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23.5K |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$20.5K |
LNAI Hedge Fund Activity: Q2 2020 in Review
33 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2020, worth a combined $10.4M — up 52% from $6.86M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LNAI positions and 3 closed out — a net gain of 1 holder — while 12 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $437K. The largest seller was Northern Trust, cutting an estimated $115K.
- 33 institutional investors held Lunai Bioworks (LNAI) as of Q2 2020, up from 32 in Q1 2020.
- Funds reported $10.4M of Lunai Bioworks stock for Q2 2020, up 52% quarter-over-quarter.
- 4 funds opened new Lunai Bioworks positions in Q2 2020 and 3 closed out, a net change of +1 holder.
- The largest Lunai Bioworks buyer in Q2 2020 was BlackRock, an estimated $437K added.
- The largest Lunai Bioworks seller in Q2 2020 was Northern Trust, an estimated $115K sold.
Based on aggregated 13F filings for Q2 2020.